1. Home
  2. HIHO vs VRAX Comparison

HIHO vs VRAX Comparison

Compare HIHO & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

N/A

Current Price

$1.18

Market Cap

5.2M

Sector

Industrials

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.46

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
VRAX
Founded
1990
2013
Country
Hong Kong
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
2.9M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
HIHO
VRAX
Price
$1.18
$0.46
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
8.6K
15.3M
Earning Date
01-20-2026
01-01-0001
Dividend Yield
10.28%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$7,080,000.00
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
$120.89
N/A
Revenue Growth
3.31
N/A
52 Week Low
$1.12
$0.35
52 Week High
$2.05
$3.20

Technical Indicators

Market Signals
Indicator
HIHO
VRAX
Relative Strength Index (RSI) 30.09 45.67
Support Level $1.12 $0.43
Resistance Level $1.28 $0.87
Average True Range (ATR) 0.05 0.07
MACD 0.01 0.00
Stochastic Oscillator 26.44 16.11

Price Performance

Historical Comparison
HIHO
VRAX

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: